Table 3.
Correlation of miR-16 expression with clinical characteristics in CAD patients.
| Variable | High expression (n = 15) | Lower expression (n = 25) | χ 2 | P value |
|---|---|---|---|---|
| Age | 0.825 | 0.364 | ||
| ≥63 | 10 (66.7) | 13 (52.0) | ||
| <63 | 5 (33.3) | 12 (48.0) | ||
| BMI | 3.536 | 0.060 | ||
| ≥26.69 | 10 (66.7) | 9 (36.0) | ||
| <26.69 | 5 (33.3) | 16 (64.0) | ||
| Current smoking | 0.008 | 0.931 | ||
| Yes | 10 (66.7) | 17 (68.0) | ||
| No | 5 (33.3) | 8 (32.0) | ||
| Hypertension | 0.036 | 0.850 | ||
| Yes | 12 (80.0) | 18 (72.0) | ||
| No | 3 (20.0) | 7 (28.0) | ||
| DM | 3.546 | 0.060 | ||
| Yes | 8 (53.3) | 6 (24.0) | ||
| No | 7 (46.7) | 19 (76.0) | ||
| PLT (∗109/L) | 0.444 | 0.505 | ||
| ≥207 | 5 (33.3) | 11 (44.0) | ||
| <207 | 10 (66.7) | 14 (56.0) | ||
| Cr (μmol/L) | 0.107 | 0.744 | ||
| ≥76.7 | 7 (46.7) | 13 (52.0) | ||
| <76.7 | 8 (53.3) | 12 (48.0) | ||
| ALT (U/L) | 0.178 | 0.673 | ||
| ≥17.8 | 5 (33.3) | 10 (40.0) | ||
| <17.8 | 10 (66.7) | 15 (60.0) | ||
| AST (U/L) | 1.153 | 0.283 | ||
| ≥19.4 | 8 (53.3) | 9 (36.0) | ||
| <19.4 | 7 (46.7) | 16 (64.0) | ||
| TC (mmol/L) | 1.504 | 0.220 | ||
| ≥4.31 | 9 (60.0) | 10 (40.0) | ||
| <4.31 | 6 (40.0) | 15 (60.0) | ||
| TG (mmol/L) | 0.264 | 0.608 | ||
| ≥2.06 | 6 (40.0) | 8 (32.0) | ||
| <2.06 | 9 (60.0) | 17 (68.0) | ||
| HDL-C (mmol/L) | 0.107 | 0.744 | ||
| ≥1.04 | 8 (53.3) | 12 (48.0) | ||
| <1.04 | 7 (46.7) | 13 (52.0) | ||
| LDL-C (mmol/L) | 1.504 | 0.220 | ||
| ≥2.95 | 9 (60.0) | 10 (40.0) | ||
| <2.95 | 6 (40.0) | 15 (60.0) | ||
| LVEF (%) | 0.444 | 0.505 | ||
| ≥61 | 8 (53.3) | 16 (64.0) | ||
| <61 | 7 (46.7) | 9 (36.0) |
CAD: coronary artery disease; BMI: body mass index; DM: diabetes mellitus; PLT: blood platelet; Cr: creatinine; ALT: alanine aminotransferase; AST: aspartate transaminase; TC: total cholesterol; TG: total glyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fractions. Data are presented as the number (%). ∗P < 0.05.